The Evaluation of APTT Reagents in Reference Plasma, Recombinant FVIII Products; Kovaltry® and Jivi® Using CWA, Including sTF/7FIX Assay
The FVIII activity in patients treated with several extended half-life FVIII (EHL-FVIII) agents different when various activated partial thromboplastin time (APTT) reagents were used. The present study examined the difference in clot waveform analysis (CWA) findings and FVIII activity when various A...
Main Authors: | Hideo Wada MD, PhD, Katsuya Shiraki MD, PhD, Takeshi Matsumoto MD, PhD, Kohshi Ohishi MD, PhD, Hideto Shimpo MD, PhD, Yumi Sakano Mrs, Hiroko Nishii Mrs, Motomu Shimaoka MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-02-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/1076029620976913 |
Similar Items
-
Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor
by: Takeshi Matsumoto MD, PhD, et al.
Published: (2019-01-01) -
The Evaluation of Hemostatic Abnormalities Using a CWA-Small Amount Tissue Factor Induced FIX Activation Assay in Major Orthopedic Surgery Patients
by: Masahiro Hasegawa MD, PhD, et al.
Published: (2021-05-01) -
Update on the Clot Waveform Analysis
by: Hideo Wada MD, PhD, et al.
Published: (2020-03-01) -
The First-Derivative Curve of the Coagulation Waveform Reveals the Cause of aPTT Prolongation
by: Daiki Shimomura PhD, et al.
Published: (2020-12-01) -
Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients
by: Hassan Abolghasemi, MD, et al.
Published: (2018-06-01)